Metrics as of 10/15/2026, 03:32 AM (Berlin time), refresh in progress.
InspireMD Stock
InspireMD, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Marvin L. Slosman
- Employees
- 127
- Market cap
- $22 M
- IPO
- 12/04/2011
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings,…
InspireMD stock: price history
1D
-6.4%
1W
-8.9%
1M
-42.2%
6M
-65.3%
YTD
-73.7%
1Y
-80.2%
2Y
-82.3%
5Y
-89.0%
10Y
-100.0%
Next earnings date
Next earnings date
10/11/2026 (in 24 days)
Volatility around earnings
~24% weaker price swings than usual
Ask the agents about InspireMD
Analyst assessment of InspireMD
PRICE TARGET LOW
US$3.00
CONSENSUS
US$3.50
MEDIAN
US$3.50
PRICE TARGET HIGH
US$4.00
0
STRONG BUY
6
BUY
1
HOLD
0
SELL
0
STRONG SELL
7
TOTAL · Buy
As of: 05/05/2026
InspireMD stock metrics
P/E
-0.94
P/B
1.09
EV/EBITDA
-0.23
RETURN ON EQUITY
-45.5%
NET MARGIN
-808.8%
DEBT/EQUITY
0.06
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
56.1%
FLOAT SHARES
26,293,520
AVG. DAILY VOLUME (30D)
92,032
Insider transactions (SEC)
Stuka Paul
Gleason Shane Thomas
Gleason Shane Thomas
Gleason Shane Thomas
Gleason Shane Thomas
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about InspireMD stock
What does InspireMD do?
InspireMD, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Marvin L. Slosman, the company employs around 127 people.
The IPO was on 12/04/2011; the stock trades on NASDAQ under the ticker NSPR.
What do analysts say about InspireMD stock?
7 analysts rate the stock, the consensus is Buy (as of 05/05/2026).
The average price target is US$3.50, ranging from US$3.00 to US$4.00, with a median of US$3.50.
This is an external assessment, not a statement by Market Jury.
When does InspireMD report next?
The next earnings date is 10/11/2026.
Around past earnings, price swings were roughly -24% stronger than usual.
Does InspireMD pay a dividend?
No, InspireMD currently does not pay a dividend.
Which stocks are comparable to InspireMD?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get InspireMD stock analyzed?
Clicking "Analyze stock" lets five strategies assess InspireMD against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.